Search Results - "Schiff, Devora"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1 by Wu, Hao, Schiff, Devora S., Lin, Yong, Neboori, Hanmanth J. R., Goyal, Sharad, Feng, Zhaohui, Haffty, Bruce G.

    Published in Radiation research (01-12-2014)
    “…Breast-conserving surgery followed by radiation therapy has become the standard of care for early stage breast cancer. However, there are some patients that…”
    Get full text
    Journal Article
  2. 2

    Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation by Schonewolf, Caitlin A, Mehta, Monal, Schiff, Devora, Wu, Hao, Haffty, Bruce G, Karantza, Vassiliki, Jabbour, Salma K

    Published in World journal of gastrointestinal oncology (15-03-2014)
    “…AIM:To investigate whether the inhibition of autophagy by chloroquine(CQ)sensitizes rectal tumors to radiation therapy(RT)or concurrent…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy by Ferro, Adam, Goyal, Sharad, Kim, Sinae, Wu, Hao, Taunk, Neil K., Schiff, Devora, Pirlamarla, Aneesh, Haffty, Bruce G.

    Published in International Journal of Breast Cancer (01-01-2013)
    “…Purpose. The purpose of this study was to evaluate acute locoregional toxicity in patients with breast cancer receiving concurrent metformin plus radiation…”
    Get full text
    Journal Article
  8. 8

    Abstract P5-05-07: Foxo3a activation contributes to the synergy of imipridone and radiation in triple-negative breast cancer by Wang, Shang-Jui, Schiff, Devora, Wu, Hao, Jhawar, Sachin, Haffty, Bruce G

    Published in Cancer research (Chicago, Ill.) (15-02-2020)
    “…Abstract Purpose/Objective: Imipridone (IMIP) is a small molecule DRD2 antagonist that has shown efficacy in preclinical and early phase clinical studies in…”
    Get full text
    Journal Article
  9. 9

    The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo by Khan, Atif J, LaCava, Stephanie, Mehta, Monal, Schiff, Devora, Thandoni, Aditya, Jhawar, Sachin, Danish, Shabbar, Haffty, Bruce G, Chen, Suzie

    Published in Oncotarget (19-04-2019)
    “…High-grade gliomas are lethal malignancies that cause morbidity and mortality due to local progression rather than metastatic spread. Our group has previously…”
    Get full text
    Journal Article
  10. 10

    VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells by Khan, Atif J, Misenko, Sarah M, Thandoni, Aditya, Schiff, Devora, Jhawar, Sachin R, Bunting, Samuel F, Haffty, Bruce G

    Published in Oncotarget (25-05-2018)
    “…DNA double-strand breaks (DSBs) can be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR). We demonstrate the selectivity of…”
    Get full text
    Journal Article
  11. 11

    Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma by Jhawar, Sachin R, Goyal, Sharad, Thandoni, Aditya, Bommareddy, Praveen, Hassan, Suemair, Schiff, Devora, Haffty, Bruce G, Kaufman, Howard, Zloza, Andrew

    Published in The Journal of immunology (1950) (01-05-2017)
    “…Abstract Talimogene laherparepvec (TVEC), an oncolytic virus, is an FDA-approved therapy that increases the overall survival of locally advanced and metastatic…”
    Get full text
    Journal Article
  12. 12

    Abstract 2765: Combination ONC201 and radiation therapy in the treatment of breast cancer by Jhawar, Sachin R., Schiff, Devora, Wu, Hao, Thandoni, Aditya, Hassan, Suemair, Allen, Joshua, Stogniew, Martin, Tarapore, Rohinton, Oster, Wolfgang, Stein, Mark, Silk, Ann W., Goyal, Sharad, Haffty, Bruce G., Zloza, Andrew

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…Abstract Purpose: Metastatic breast cancer patients continue to have poor outcomes on current treatments, and thus, novel therapies in combination with…”
    Get full text
    Journal Article
  13. 13

    Riluzole Enhances Ionizing Radiation-Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo by KHAN, Atif J, WALL, Brian, AHLAWAT, Stuti, GREEN, Camille, SCHIFF, Devora, MEHNERT, Janice M, GOYDOS, James S, CHEN, Suzie, HAFFTY, Bruce G

    Published in Clinical cancer research (01-04-2011)
    “…Brain metastases are a common preterminal event in patients with metastatic melanoma and require radiation therapy. Our group has previously shown that human…”
    Get full text
    Journal Article
  14. 14

    Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells by Wall, Brian A., Wangari-Talbot, Janet, Shin, Seung S., Schiff, Devora, Sierra, Jairo, Yu, Lumeng J., Khan, Atif, Haffty, Bruce, Goydos, James S., Chen, Suzie

    Published in Pigment cell and melanoma research (01-03-2014)
    “…Summary Gain of function of the neuronal receptor, metabotropic glutamate receptor 1 (Grm1), was sufficient to induce melanocytic transformation in vitro and…”
    Get full text
    Journal Article
  15. 15

    Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy by Patel, Akshar N, Goyal, Sharad, Wu, Hao, Schiff, Devora, Moran, Meena S, Haffty, Bruce G

    Published in Breast cancer research and treatment (01-04-2011)
    “…The mediator of DNA damage checkpoint protein 1 (MDC1) regulates cell cycle checkpoints and recruits repair proteins to sites of double-stranded DNA damage…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Abstract 2489: Targeting pro-survival BCL-2 family members increases radiation sensitivity in breast cancer cells by Wu, Hao, Schiff, Devora S., Goyal, Sharad, Neboori, Hanmanth J.R., Haffty, Bruce G.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract In previous studies we have shown that BCL-2 expression was associated with an increased risk of local recurrence in patients with early stage breast…”
    Get full text
    Journal Article
  18. 18

    Disruption of GRM 1‐mediated signalling using riluzole results in DNA damage in melanoma cells by Wall, Brian A., Wangari‐Talbot, Janet, Shin, Seung S., Schiff, Devora, Sierra, Jairo, Yu, Lumeng J., Khan, Atif, Haffty, Bruce, Goydos, James S., Chen, Suzie

    Published in Pigment cell and melanoma research (01-03-2014)
    “…Summary Gain of function of the neuronal receptor, metabotropic glutamate receptor 1 ( G rm1), was sufficient to induce melanocytic transformation in vitro and…”
    Get full text
    Journal Article
  19. 19

    CD8+, Radiosensitive T Cells of Parental Origin, Oppose Cells Capable of Down-Regulating Cytotoxicity in Murine Acute Lethal Graft-versus-Host Disease by Mann, Richard A., Schiff, Devora, Jetzt, Amanda E., Ron, Yacov, Singh, Manjeet, Singh, Ajay B.

    Published in Clinical immunology and immunopathology (01-12-1998)
    “…Murine graft-versus-host (GVH) disease takes two forms depending upon the parental/F1 strain combination employed. Anemia, lymphopenia, hypogammaglobulinemia,…”
    Get full text
    Journal Article